Pathophysiology of HTN Flashcards

1
Q

key steps for proper BP measurements

A
  1. properly prepare the pt
    -rest quietly for ~5 min
    -pt should be relaxed, sitting, both feet on floor, remove clothing under the cuff, no recent caffeine or smoking
  2. use proper technique for BP measurements
    -BP cuff size should be appropriate
    -use an upper arm measurement, around the level of the heart/right atrium
  3. take the proper measurements needed for dx and tx of elevated BP/HTN
  4. properly document BP readings & average multiple readings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

normal blood pressure

A

SBP < 120 AND DBP < 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

elevated blood pressure

A

SBP 120-129 AND DBP < 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

stage 1 HTN

A

SBP 130-139 OR DBP 80-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

stage 2 HTN

A

SBP 140+ OR DBP 90+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

primary (essential) HTN - defined

A

*unknown cause
*likely genetic & environmental influences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

secondary HTN - defined & when to suspect it

A

*due to an identifiable cause
*consider secondary HTN if…
-refractory or resistant HTN
-young age of onset (<30 in adults)
-associated hypokalemia
-abrupt onset or significant increase in HTN in a short period of time
-very severe HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

refractory/resistant hypertension - defined

A

*blood pressure that is still not at goal despite treatment with 3 medications at max tolerated dose, all from different classes, including a diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hypertensive urgency vs. emergency

A

*both have severe HTN: BP 180/120 or higher
*HTN urgency: no end organ damage
*HTN EMERGENCY: SIGNS OF END ORGAN DAMAGE:
-pulmonary edema
-papilledema, ICH
-MI/elevated troponins
-AKI
-aortic dissection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

white coat hypertension - defined

A

*HTN only seen in doctor’s office
*normal BP at home, however, pt is more nervous in medical setting, so blood pressures are higher
*this can be confirmed with 24h ambulatory BP monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

masked hypertension - defined

A

*opposite of white coat HTN
*blood pressure is NORMAL in the doctor’s office but runs HIGH AT HOME
*detected through 24h ambulatory BP monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lifestyle interventions to treat HTN

A

*WEIGHT LOSS
*heart healthy diet (ex. DASH diet)
*low salt diet
*exercise/increased physical activity
*decrease alcohol consumption
*treatment of OSA with CPAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

suspected pathogenic mechanisms in HTN

A
  1. abnormal kidney handling of sodium & plasma volume
  2. activation of sympathetic nervous system
  3. activated RAAS
  4. likely other environmental & genetic factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

effects of abnormal kidney handling of sodium & plasma volume → HTN

A

*excess Na+ (and thus excess water) content in blood → higher blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pressure natriuresis

A

*mean arterial pressure increases as sodium intake increases

*2 clinical categories:
1. salt sensitive:
-more likely to respond to diuretic and dietary salt restriction
-have lower renin levels
2. salt insensitive:
-more likely to respond to RAAS blockade
-have higher renin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

effects of RAAS → HTN

A

angiotensinogen → angiotensin I → angiotensin II → aldosterone
*end result = INCREASED BLOOD PRESSURE / VOLUME

*rate limiting step = RENIN RELEASE (recall: renin converts angiotensinogen to angiotensin I)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

angiotensin II - effects leading to increased blood pressure

A

*sodium reabsorption
*water reabsorption (increased ADH)
*vasoconstriction
*increased sympathetic tone
*increased salt appetite
*increased thirst drive

end result: increased BP/blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

aldosterone - effects leading to increased blood pressure

A

*salt reabsorption → increased blood volume
*potassium excretion
*acid excretion

end result: increased BP/blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

factors that cause renin release

A

*decreased renal perfusion (systemic hypotension or low afferent arteriole pressure)
*increased sympathetic activity/tone
*decreased flow through tubules or decreased distal Na+ delivery (detected by macula densa)
*beta1 adrenergic stimulation
*low sodium diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

effects of aldosterone in the principal cell in the collecting duct

A

aldosterone (made by adrenal cortex) binds mineralocorticoid receptor (MR) inside principal cells → increased activity of Na+/K+ ATPase AND increased activity of ENaC → increased reabsorption of sodium into blood & wasting of potassium in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

medications that turn off steps of RAAS cascade

A
  1. ACE inhibitors (-prils) - block conversion of Ang I to Ang II
  2. ARBs (-sartans) - block conversion of Ang II to aldosterone
  3. aldosterone antagonists (spironolactone, epleronone) - block effects of aldosterone
22
Q

effects of increased salt intake on RAAS activity

A

*as salt intake increases, the RAAS system should be turned OFF

23
Q

risk factors for HTN

A

*obesity
*decreased nephron number
*family hx of HTN
*race (more common in Black pts)
*increasing age
*smoking
*male sex
*substantial alcohol use
*sedentary lifestyle
*low SES
*insulin resistance
*high dietary sodium intake

24
Q

genetic disorders associated with HTN

A
  1. Liddle Syndrome
  2. Syndrome of Apparent Mineralocorticoid Excess (SAME)
  3. Pseudohypoaldosteronism type 2 / Gordon Syndrome
  4. Glucocorticoid Remediable Hyperaldosteronism (GRA)
25
Q

Liddle Syndrome - inheritance pattern & genetics

A

*autosomal dominant
*gain of function mutation of the ENaC channel located in the apical membrane on the principal cell in the collecting duct
*results in excessive Na+ reabsorption and excessive K+ wasting

26
Q

Liddle Syndrome - electrolyte impacts

A
  1. excessive Na+ reabsorption
  2. hypokalemia (excessive K+ wasting)
  3. metabolic alkalosis
  4. hypertension
  5. low-to-normal serum aldosterone
27
Q

Liddle Syndrome - clinical presentation

A

*young person with high blood pressure
*family hx of HTN (particularly at a young age)
*hypokalemia
*metabolic alkalosis (due to K+/H+ exchange in the alpha-intercalated cells)

METABOLIC ALKALOSIS + HYPOKALEMIA + HTN (low serum aldosterone)

28
Q

Liddle Syndrome - effects on RAAS

A

*gain of function of ENaC channels → excessive Na+ reabsorption → volume expansion → DECREASED RENIN
*decreased renin → decreased Ang II → decreased aldosterone

29
Q

Liddle Syndrome - treatment

A

*block ENaC: potassium sparing diuretics: amiloride, triamterene

30
Q

primary hyperaldosteronism vs. Liddle Syndrome

A

*both: HTN, hypokalemia, metabolic alkalosis
*Liddle Syndrome: LOW ALDOSTERONE
*primary hyperaldosteronism: HIGH ALDOSTERONE

31
Q

Syndrome of Apparent Mineralocorticoid Excess (SAME) - inheritance pattern & genetics

A

*autosomal recessive
*mutation of 11 beta-hydroxysteroid dehydrogenase, causing it to be inactivated
*this enzyme normally converts cortisol to cortisone; inactivation of enzyme → activation of mineralocorticoid receptors by excess cortisol

*notably - a LOT of black licorice ingestion can cause a similar phenotype (glycyrrhizic or glycyrrhetinic acids in licorice inhibits the same enzyme)

32
Q

Syndrome of Apparent Mineralocorticoid Excess (SAME) - clinical features

A

*infants with low birth weight, failure to thrive
*severe HTN
*hypokalemia
*metabolic alkalosis

*low serum aldosterone (cortiol tries to be the SAME as aldosterone)

33
Q

Syndrome of Apparent Mineralocorticoid Excess (SAME) - effects on RAAS

A

*cortisol is stimulating the mineralocorticoid receptor (same receptor that aldosterone stimulates)

*increased Na+ reabsorption → volume expansion → decreased renin
*decreased renin → decreased Ang II → decreased aldosterone

34
Q

pseudohypoaldosteronism type 2 / Gordon Syndrome - inheritance pattern & genetics

A

*autosomal dominant
*gain of function mutation of the Na+/Cl- cotransporter in DCT (opposite of thiazide diuretics; opposite of Gitelman syndrome)

35
Q

pseudohypoaldosteronism type 2 / Gordon Syndrome - electrolyte impacts

A

*excessive Na+ reabsorption → increased blood volume
*less delivery of Na+ to the cortical collecting duct, so K+ cannot be excreted

36
Q

pseudohypoaldosteronism type 2 / Gordon Syndrome - clinical presentation

A

*HTN
*HYPERKALEMIA
*metabolic acidosis
*normal kidney function

37
Q

pseudohypoaldosteronism type 2 / Gordon Syndrome - treatment

A

*thiazide diuretics

38
Q

glucocorticoid remediable hyperaldosteronism (GRA) - inheritance pattern & genetics

A

*autosomal dominant
*genetic crossover between 2 genes causes the creation of a chimeric aldosterone synthase gene which is controlled by ACTH release instead of Ang II

39
Q

glucocorticoid remediable hyperaldosteronism (GRA) - clinical presentation

A

*HTN (resistant, often at a young age)
*metabolic alkalosis
*family hx of HTN and/or premature hemorrhagic stroke

40
Q

glucocorticoid remediable hyperaldosteronism (GRA) - treatment

A

*glucocorticoids to suppress ACTH release

41
Q

Bartter Syndrome - inheritance pattern & genetics

A

*autosomal recessive
*inactivating mutation in the NKCC channel in thick ascending loop of Henle (loop diuretic channel)

note - this is a cause of HYPOtension

42
Q

Bartter Syndrome - clinical presentation

A

*presents in infancy/childhood
*growth delay
*volume depletion
*hypokalemia, hypomagnesemia, hypochloremia, metabolic alkalosis
*HYPERCALCIURIA
*usually HYPOTENSION or normotension

remember - pts with Bartter Syndrome act like they have been on LOOP diuretics

metabolic alkalosis + hypokalemia + hypercalciuria + hypotension

43
Q

Gitelman Syndrome - inheritance pattern & genetics

A

*autosomal recessive
*inactivating mutation in the Na+/Cl- cotransporter in the DCT
*acsts like a thiazide diuretic (causes hypercalcemia)
*opposite of Gordon syndrome

note - this is a cause of HYPOtension

44
Q

Gitelman Syndrome - clinical presentation

A

*usually presents in childhood, teen, or early adult years
*volume depletion
*hypokalemia, hypomagnesemia, hypochloremia, metabolic alkalosis
*HYPOCALCIURIA
*usually HYPOTENSION or normotension

remember - pts with Gitelman Syndrome act like they are on THIAZIDE diuretics

metabolic alkalosis + hypokalemia + hypocalciuria + hypomagnesemia + hypotension

45
Q

Bartter Syndrome vs. Gitelman Syndrome

A

*HIGH URINE CALCIUM (hypocalcemia) = Bartter (acts like a loop diuretic)
*LOW URINE CALCIUM (hypercalcemia) = Gitelman (acts like a thiazide diuretic)

46
Q

pseudohypoaldosteronism type 1 - inheritance pattern & genetics

A

*autosomal dominant or sporadic
*loss of function defect in ENaC or mineralocorticoid receptor
*essentially, unresponsive to the effects of aldosterone

47
Q

pseudohypoaldosteronism type 1 - clinical presentation

A

*presents in neonatal period or early infancy
*salt wasting, failure to thrive
*HYPOTENSION
*hyperkalemia

48
Q

pseudohypoaldosteronism type 1 - treatment

A

high salt diet/NaCl supplements

49
Q

monogenic disorders of BP regulation: ENaC channel in principal cells of collecting duct

A

*Liddle’s Syndrome = gain of ENaC function → hypertension
*Pseudohypoaldosteronism type I = loss of ENaC function → hypotension

50
Q

monogenic disorders of BP regulation: NKCC channel in loop of Henle

A

*Bartter’s Syndrome = loss of NKCC function → hypotension

51
Q

monogenic disorders of BP regulation: Na+/Cl- cotransporter in DCT

A

*pseudohypoaldosteronism type 2 (Gordon) = gain of NCC function → hypertension
*Gitelman’s syndrome = loss of NCC function → hypotension